The early study result from Scripps Research suggests that switchable CAR T cells are not only safe to use for patients with B cell cancers, but comparatively safer and more effective than some CAR T therapies currently on the market.
Subscribe to:
Post Comments (Atom)
< + > Happy New Year!
Happy New Year to all of you! 2025 flew by here at Healthcare IT Today. Hopefully it was an amazing year for you. 2026 is shaping up to ...
No comments:
Post a Comment